These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21425966)

  • 1. Interview with Dr Bernard Pécoul, Executive Director of the Drugs for Neglected Diseases Initiative.
    Pécoul B
    Future Med Chem; 2009 May; 1(2):243-8. PubMed ID: 21425966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interview with Solomon Nwaka.
    Nwaka S
    Future Med Chem; 2011 Sep; 3(11):1339-44. PubMed ID: 21879840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
    Yamada H; Hirabayashi F; Brünger C
    Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
    Ioset JR; Chang S
    Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future treatment options for human African trypanosomiasis.
    Jones AJ; Avery VM
    Expert Rev Anti Infect Ther; 2015; 13(12):1429-32. PubMed ID: 26414688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery and human African trypanosomiasis: a disease less neglected?
    Ferrins L; Rahmani R; Baell JB
    Future Med Chem; 2013 Oct; 5(15):1801-41. PubMed ID: 24144414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery and development for neglected diseases: the DNDi model.
    Chatelain E; Ioset JR
    Drug Des Devel Ther; 2011 Mar; 5():175-81. PubMed ID: 21552487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of E1224 by leveraging a strategic partnership for the medicines creation against neglected tropical diseases.
    Hata K
    Parasitol Int; 2021 Apr; 81():102278. PubMed ID: 33370607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public-private partnership: from there to here.
    Croft SL
    Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interview with James McKerrow.
    McKerrow J
    Future Med Chem; 2011 Aug; 3(10):1243-6. PubMed ID: 21859298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Straight talk with...BT Slingsby. Interviewed by Cassandra Willyard.
    Slingsby BT
    Nat Med; 2013 Dec; 19(12):1553. PubMed ID: 24309642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
    Johnston KL; Ford L; Taylor MJ
    J Biomol Screen; 2014 Mar; 19(3):335-43. PubMed ID: 24241712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for neglected diseases: part I.
    Kaneko T
    Future Med Chem; 2011 Aug; 3(10):1235-7. PubMed ID: 21859296
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development and Distribution of Drugs for NTDs: Efforts of One Pharmaceutical Company].
    Asada M
    Yakugaku Zasshi; 2016; 136(2):223-30. PubMed ID: 26831797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fexinidazole and Human African Trypanosomiasis: good news for this important neglected tropical disease.
    Bayão TS; Cupertino MDC; Gomes AP; Siqueira-Batista R
    Rev Soc Bras Med Trop; 2019; 52():e20190176. PubMed ID: 31596351
    [No Abstract]   [Full Text] [Related]  

  • 16. [Status of research and development for control of tropical diseases: hypocrisy, indifference or lack of coordination].
    Millet P
    Med Trop (Mars); 2006 Dec; 66(6):542-8. PubMed ID: 17286017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global health: neglected diseases and access to medicines.
    Garg NJ
    Infect Dis Clin North Am; 2011 Sep; 25(3):639-51, ix-x. PubMed ID: 21896364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neglected tropical diseases: moving beyond mass drug treatment to understanding the science.
    Mahmoud A; Zerhouni E
    Health Aff (Millwood); 2009; 28(6):1726-33. PubMed ID: 19887413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for neglected diseases: part II.
    Kaneko T
    Future Med Chem; 2011 Sep; 3(11):1329-30. PubMed ID: 21879837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.